Introducing Adam Cohen, Co-Founder, President and CEO, Bellesoma

Bellesoma is transforming the field of women’s breast health through its software-guided surgical platform that is improving quality of life outcomes, not only in surgical aesthetics, but also in pioneering procedures in breast reconstructive surgery, with a direction towards women who have undergone lumpectomies and mastectomies after being diagnosed with breast cancer. Bellesoma is currently available in the market and desires to scale it’s operations to make their surgical solution available to women around the globe.

Adam Cohen, the CEO, co-founded Bellesoma after experiencing his wife’s personal journey with breast surgery. He has had a rewarding career as a serial entrepreneur. He achieved his first successful exit within 5-years from company he started immediately after receiving his undergraduate degree from the University of Illinois - Gies School of Business. From there he took an industrial supply company from $125M to $225M in sales with an equity exit followed by a successful turnaround of financial services company as President. Adam also holds an MBA from Northwestern University – Kellogg School of Management.

Adam currently lives in Chicago, IL with his wife and two teenage sons.

Introducing Paul Denslow, Chief Executive Officer, Shoreline Biome

Shoreline Biome have developed a breakthrough, patented microbiome assay, and proprietary data driven analysis platform. The technology can identify ALL of the bacteria in a sample, at the strain level – the level required for ACTION. With it being high throughput and low cost, the Microbiome can finally be unlocked for personalized patient care and precision research alike. With the technology already commercialized, and clients including NASA and an array of pharma companies, Shoreline Biome will play an exciting and central role in the Microbiome revolution.

Paul Denslow is an experienced bio-tech investor, syndicate-lead and consultant, who knows how to spot opportunities in the market place and deliver them effectively and efficiently. He is a strong believer in the power of platforms and big data to drive enhanced health outcomes. Paul joined Shoreline Biome because of the Company’s potential to do exactly this, and because of the outstanding team.

Originally from the UK, Paul has worked in Asia, Europe and the US, holding senior roles at HSBC and Standard Chartered, with over 15 years of experience in banking, including running a large and successful regional financial markets business. He is an avid sailor, with 7 Newport to Bermuda Races and a leg of an around-the-world the round yacht race (from Singapore to Cape Town) to his name. He received his BSc. from the University of Bath.

Learn more about Shoreline Biome by visiting https://shorelinebiome.com/